Friday, July 10, 2026

Drug profile · INN

clostridium botulinum, serotype e, neurotoxin (150 kda)

clostridium botulinum, serotype e, neurotoxin (150 kda) (BOEY) is an FDA-listed pharmaceutical active ingredient.

EMA: unknown Musculo-skeletal system (M03) M03AX01
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — clostridium botulinum, serotype e, neurotoxin (150 kda)
Class
Musculo-skeletal system (M03)
Route
Patents
0
Programs
2
Data quality
0.83

Quick answer

clostridium botulinum, serotype e, neurotoxin (150 kda) (BOEY) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN clostridium botulinum, serotype e, neurotoxin (150 kda)
Brand BOEY
Therapeutic class Musculo-skeletal system (M03)
ATC code M03AX01

Approval history

Authority Status Date
EMA unknown

Pipeline programs

  1. M602011084 Phase 3 · Merz Therapeutics · Chronic migraine
  2. M602011085 Phase 3 · Merz Therapeutics · Episodic migraine

Related & competitor drugs

  1. allopurinol Musculo-skeletal system (M04)
  2. colchicine Musculo-skeletal system (M04)
  3. denosumab Musculo-skeletal system (M05)
  4. eteplirsen Musculo-skeletal system (M09)
  5. febuxostat Musculo-skeletal system (M04)
  6. ibandronic acid Musculo-skeletal system (M05)

Frequently asked questions

What is clostridium botulinum, serotype e, neurotoxin (150 kda)?

clostridium botulinum, serotype e, neurotoxin (150 kda) (BOEY) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for clostridium botulinum, serotype e, neurotoxin (150 kda)?

BOEY is a marketed brand name for clostridium botulinum, serotype e, neurotoxin (150 kda). Check FDA Drugs@FDA for the current US label holder and prescribing information.